№ files_lp_4_process_2_46933
File format: docx
Character count: 49117
File size: 123 KB
Year:
2021
Region / city:
Manchester, United Kingdom
Topic:
Liquid biopsy in biliary tract cancer
Document type:
Review article
Organization / institution:
The Christie NHS Foundation Trust, University of Manchester
Authors:
Shotton R, Lamarca A, Valle J, McNamara MG
Target audience:
Researchers, medical professionals
Period of action:
Not specified
Date of approval:
August 11, 2021
Date of revisions:
June 14, 2021
Date of publication:
2021
Keywords:
Biliary tract cancer, Liquid biopsy, Circulating tumour DNA, Cell free DNA, Circulating tumour cells, Biomarkers
Clinical trials:
Currently recruiting trials involving liquid biopsy in biliary tract cancer
Abstract:
This article reviews the potential role of liquid biopsies in diagnosing, predicting, and monitoring biliary tract cancers, including circulating tumour DNA, microRNA, and tumour cells, along with current clinical trials.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2001
Region / City:
UK
Subject:
Dermatology, Nursing, Skin Cancer
Document Type:
Protocol
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Registered Nurses, Dermatology Practitioners
Period of Effect:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Number of patients:
80
Setting:
Intensive care unit
Procedure:
Transvenous renal biopsy
Study design:
Observational analytical study
Statistical methods:
Student’s t-test; Wilcoxon’s rank test; χ2 test; logistic regression with backward-stepwise variable elimination
Outcomes assessed:
Composite complication endpoint; acute tubular necrosis diagnosis; diagnostic yield; in-ICU mortality; therapeutic consequences
Variables analyzed:
Demographic characteristics; clinical scores (SOFA, SAPS II); laboratory parameters; anticoagulation and antiplatelet therapy; bleeding-risk factors; vasopressor use; mechanical ventilation; extracorporeal membrane oxygenation
Time comparison:
TVRB performed before 2012 vs after 2012; biopsy after 2015
Therapeutic interventions evaluated:
Corticosteroids; cyclophosphamide; plasmapheresis; intravenous immunoglobulins; rituximab; eculizumab; calcineurin inhibitors; anticoagulation
Definition of composite endpoint:
Renal hematoma; macroscopic hematuria; transfusion during days 1–3 post-TVRB; SOFA score increase ≥1 point from TVRB day to day +3; hemoglobin decrease ≤ –2 g/dL from TVRB day to day +3
Year:
2019
Region / city:
Cambridge, United Kingdom
Topic:
Hereditary diffuse gastric cancer, endoscopic surveillance, biopsy techniques
Document type:
Clinical Trial Study
Organization / institution:
University of Cambridge
Target audience:
Medical professionals, researchers, and clinicians involved in hereditary cancer surveillance
Period of action:
October 2017 - December 2018
Approval date:
Not specified
Date of changes:
Not specified
Year:
2025
Region / city:
Rivers State, Nigeria
Subject:
Lymphadenopathy, Histopathological analysis
Document Type:
Research Study
Institution:
Rivers State University Teaching Hospital
Author:
Not specified
Target Audience:
Medical professionals, Researchers
Study Period:
1st January 2019 – 31st December 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025
Region / city:
Rivers State, Nigeria
Subject:
Lymphadenopathy, Histopathological analysis
Document Type:
Research Article
Organization / Institution:
Rivers State University Teaching Hospital
Author:
Not specified
Target Audience:
Healthcare professionals, researchers in the medical field
Effective Date:
January 1, 2019
Date of Last Update:
December 31, 2025
Document type:
Supplementary methods section
Scientific field:
Molecular medicine and tumor immunology
Techniques described:
Immunofluorescence histology, multiplex antibody staining, next-generation sequencing
Biological material:
Tumor biopsy FFPE tissue sections
Immune markers analyzed:
CD8+, CD4+, Granzyme B
Sequencing platforms:
Illumina NovaSeq 6000
Bioinformatics tools:
trim_galore, STAR, featureCounts, DESeq2, GATK HaplotypeCaller, MuTect, Vardict
Genome reference:
Human genome hg38 with appended ONCOS-102 genome
Imaging equipment:
Panoramic 250 FLASH whole-slide scanner
Institutions mentioned:
Institute for Molecular Medicine Helsinki; Personalis Inc., California, USA
Sample preparation:
3.5 μm FFPE tissue sections
Staining reagents:
TSA 647, TSA 750, DAPI nuclear stain
Analysis focus:
Detection and quantification of immune cell infiltrates and differential gene expression in tumor biopsies
Year:
2010-2024
Region / city:
Asia-Pacific
Subject:
Hepatology
Document Type:
Clinical Practice Guidelines
Organization / Institution:
Asian Pacific Association for the Study of the Liver (APASL)
Author:
APASL
Target Audience:
Healthcare professionals
Period of validity:
2010-2024
Date of approval:
2010
Date of revisions:
2024
Context:
Collection of clinical practice guidelines and consensus statements issued by the Asian Pacific Association for the Study of the Liver on various hepatological conditions, including hepatocellular carcinoma, hepatitis B and C, liver transplantation, and metabolic diseases.
Year:
2010–2022
Region / City:
Hyogo, Japan
Subject:
Biliary Tract Cancer, Sarcopenia, Surgical Outcomes
Document Type:
Clinical Study
Institution:
Meiwa Hospital, Department of Surgery
Authors:
Shinichi Ikuta, Tsukasa Aihara, Takayoshi Nakajima, Meidai Kasai, Naoki Yamanaka
Target Audience:
Oncologists, Surgeons, Clinical Researchers
Patient Cohort:
211 patients undergoing BTC resection
Primary Tumor Sites:
Intrahepatic bile duct, Extrahepatic bile duct, Gallbladder, Ampulla of Vater
Follow-up Method:
Disease-specific survival (DSS), Relapse-free survival (RFS)
Ethics Approval:
Institutional Ethics Committee of Meiwa Hospital, approval No. 2022-36
Year:
2023
Region / city:
Australia
Subject:
Pharmaceutical treatment for primary biliary cholangitis
Document type:
Authority submission for PBS listing
Organization:
Emerge Health Pty Ltd
Author:
Emerge Health Pty Ltd
Target audience:
Healthcare professionals, gastroenterologists, hepatologists, prescribers
Period of validity:
Ongoing
Approval date:
Not specified
Date of changes:
Not specified
Year:
2026
Region / City:
N/A
Subject:
Medical Imaging, Biliary Obstruction
Document Type:
Research Article
Institution:
N/A
Author:
Zhou Z, Wu HY
Target Audience:
Medical Professionals
Period of Validity:
N/A
Date of Approval:
N/A
Date of Amendments:
N/A
Year:
2023
Region / City:
Munich, Germany; Gliwice, Poland; Göttingen, Germany
Subject:
Acute pancreatitis, Biliary pancreatitis, Microlithiasis, Sludge, Machine learning
Document type:
Research article
Organization / Institution:
LMU University Hospital, Maria Sklodowska-Curie National Research Institute of Oncology, University Medical Center Göttingen
Author:
Simon Sirtl, Michal Żorniak, Eric Hohmann, Georg Beyer, Miriam Dibos, Annika Wandel, Veit Phillip, Christoph Ammer-Herrmenau, Albrecht Neesse, Christian Schulz, Jörg Schirra, Julia Mayerle, Ujjwal Mukund Mahajan
Target audience:
Medical researchers, healthcare professionals, gastroenterologists
Period of validity:
2015–2020
Approval date:
August 28, 2023
Date of changes:
N/A
Corresponding author:
Julia Mayerle
Supported by:
Deutsche Forschungsgemeinschaft (German Research Foundation), United European Gastroenterology Research Fellowship
Keywords:
Machine learning, Endosonography, Acute pancreatitis, Microlithiasis, Sludge
DOI:
https://dx.doi.org/10.3748/wjg.v29.i35.5138
Context description:
A retrospective study on the development of a machine learning-based model to predict biliary sludge and microlithiasis in patients with idiopathic acute pancreatitis, supporting decision-making for endosonography.
Note:
Year
Theme:
Medical, Oncology
Document Type:
Referral Form
Organization / Institution:
University Hospitals Birmingham
Target Audience:
Healthcare professionals, GPs
Context:
Form for urgent referral of patients suspected of having urological cancers to appropriate medical specialists.
Year:
2025
Region / city:
Victoria
Subject:
Cancer biomarkers
Document type:
Regulatory document
Organization / institution:
Department of Health
Author:
Unknown
Target audience:
Healthcare professionals, pathology laboratories
Effective date:
18 September 2025
Date of approval:
Unknown
Date of amendments:
Unknown
Year:
2024
Note:
Region / city
Subject:
Urological Cancer Referrals
Document type:
Guidelines
Organization:
UHB (University Hospitals Birmingham)
Target audience:
Healthcare professionals, general practitioners
Effective period:
From April 2024
Keywords:
PSA, DRE, urological cancer, referral, bladder cancer, prostate cancer, biopsy, UTI, urology
Year:
2023
Region / City:
New Zealand
Topic:
Bowel cancer screening, interval cancers, screening sensitivity
Document Type:
Report
Organization:
New Zealand Cancer Registry
Author:
Not specified
Target Audience:
Healthcare professionals, researchers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2019
Region / City:
Not specified
Subject:
Gynecological cancer management
Document type:
Guidelines
Institution:
Not specified
Author:
Not specified
Target audience:
Healthcare professionals in gynecology
Period of validity:
Not specified
Approval date:
Not specified
Revision date:
Not specified
Year:
2025
Region / City:
Westminster
Topic:
Cancer care, governance, NHS, cancer treatment
Document Type:
Work Programme
Organization:
APPG on Less Survivable Cancers
Author:
APPG on Less Survivable Cancers Secretariat
Target Audience:
APPG members, MPs, healthcare professionals
Period of Action:
September 2025 - January 2026
Approval Date:
September 2025
Date of Changes:
Not specified
Context:
This work programme outlines the planned activities and sessions for the APPG on Less Survivable Cancers, focusing on improving cancer care governance, treatment delays, and collaboration with other parliamentary groups.
Version:
4.2.0.0
Protocol Posting Date:
June 2023
Note:
CAP Laboratory Accreditation Program
Protocol Required Use Date:
March 2024
Authors:
Raja R. Seethala, MD; Justin A. Bishop, MD; William C. Faquin, MD, PhD; Shao Hui Huang, MD; Nora Katabi, MD; William Lydiatt, MD; Brian O’Sullivan, MB BCh; Snehal Patel, MD; Jason Pettus, MD; Lindsay Williams, MD
Tumor Types:
Carcinoma, Mucosal Melanoma
Procedures:
Resection
Accreditation Requirements:
Core and conditional data elements required for definitive primary cancer resections
Optional Data Elements:
Identified with “+” for local practice consideration
Excluded Specimens:
Biopsy, primary resection with no residual cancer, cytologic specimens, squamous cell carcinoma in situ
Excluded Tumor Types:
Sarcoma, lymphoma, carcinomas of dry vermillion lip
Reporting Format:
Synoptic reporting of all required data elements
Standards Referenced:
AJCC-UICC 8, WHO 5th edition, pTNM classification
Year:
2023
Note:
Region / city
Subject:
Oncology
Document Type:
Protocol
Organization / Institution:
CAP
Author:
Raja R. Seethala, MD; Justin A. Bishop, MD; William C. Faquin, MD, PhD; Shao Hui Huang, MD; Nora Katabi, MD; William Lydiatt, MD; Brian O’Sullivan, MB BCh; Snehal Patel, MD; Jason Pettus, MD; Lindsay Williams, MD
Target Audience:
Pathologists, medical professionals in oncology
Effective Period:
March 2024
Approval Date:
June 2023
Date of Changes:
June 2023
Year:
2021
Region / City:
Global
Topic:
Smoking, Digestive Cancers, Epidemiology
Document Type:
Research Report
Organization:
Global Burden of Disease Study
Author:
Not specified
Target Audience:
Health professionals, researchers, policymakers
Period of Action:
1990–2021
Date of Approval:
Not specified
Date of Changes:
Not specified